Adithya Cattamanchi

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda
    Christina Yoon
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA
    PLoS ONE 7:e48599. 2012
  2. pmc Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa
    David W Dowdy
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    PLoS ONE 8:e70485. 2013
  3. pmc Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 7:e39838. 2012
  4. pmc Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, USA
    BMC Infect Dis 10:75. 2010
  5. pmc Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting
    A Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, USA
    Int J Tuberc Lung Dis 13:1130-6. 2009
  6. pmc Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA, USA
    BMC Infect Dis 9:53. 2009
  7. pmc Integrated strategies to optimize sputum smear microscopy: a prospective observational study
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, California, USA
    Am J Respir Crit Care Med 183:547-51. 2011
  8. pmc Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco GeneralHospital, 1001 Potrero Ave, San Francisco, CA 94110, USA
    Clin Infect Dis 48:179-85. 2009
  9. pmc Poor performance of universal sample processing method for diagnosis of pulmonary tuberculosis by smear microscopy and culture in Uganda
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, USA
    J Clin Microbiol 46:3325-9. 2008
  10. doi Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection
    Adithya Cattamanchi
    University of California San Francisco, San Francisco General Hospital, San Francisco, CA 94110, USA
    Chest 133:875-80. 2008

Collaborators

Detail Information

Publications37

  1. pmc Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda
    Christina Yoon
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA
    PLoS ONE 7:e48599. 2012
    ..The clinical impact of Xpert MTB/RIF for tuberculosis (TB) diagnosis in high HIV-prevalence settings is unknown...
  2. pmc Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa
    David W Dowdy
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    PLoS ONE 8:e70485. 2013
    ..To compare the population-level impact of two World Health Organization-endorsed strategies for improving the diagnosis of tuberculosis (TB): same-day microscopy and Xpert MTB/RIF (Cepheid, USA)...
  3. pmc Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 7:e39838. 2012
    ..However, assessment of local immune responses has been reported to improve the accuracy of TB diagnosis...
  4. pmc Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, USA
    BMC Infect Dis 10:75. 2010
    ..Our objective was to examine the accuracy of a commercial IGRA for diagnosis of active tuberculosis in HIV-infected persons...
  5. pmc Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting
    A Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, USA
    Int J Tuberc Lung Dis 13:1130-6. 2009
    ..Mulago Hospital, Kampala, Uganda...
  6. pmc Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA, USA
    BMC Infect Dis 9:53. 2009
    ..Sputum concentration increases the sensitivity of smear microscopy for the diagnosis of tuberculosis (TB), but few studies have investigated this method in human immunodeficiency virus (HIV)-infected individuals...
  7. pmc Integrated strategies to optimize sputum smear microscopy: a prospective observational study
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, California, USA
    Am J Respir Crit Care Med 183:547-51. 2011
    ..The standard approach to smear microscopy involves sputum collection over multiple days and examination of sputum smears by light microscopy (LM), an insensitive and time-consuming technique...
  8. pmc Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco GeneralHospital, 1001 Potrero Ave, San Francisco, CA 94110, USA
    Clin Infect Dis 48:179-85. 2009
    ..Risk factors and treatment outcomes under program conditions for isoniazid (INH)-monoresistant tuberculosis have not been well described...
  9. pmc Poor performance of universal sample processing method for diagnosis of pulmonary tuberculosis by smear microscopy and culture in Uganda
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, USA
    J Clin Microbiol 46:3325-9. 2008
    ....
  10. doi Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection
    Adithya Cattamanchi
    University of California San Francisco, San Francisco General Hospital, San Francisco, CA 94110, USA
    Chest 133:875-80. 2008
    ..In patients with HIV infection, the radiographic findings of M kansasii lung disease are not well described...
  11. pmc Does bleach processing increase the accuracy of sputum smear microscopy for diagnosing pulmonary tuberculosis?
    A Cattamanchi
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, CA 94110, USA
    J Clin Microbiol 48:2433-9. 2010
    ..Further research should focus on alternative approaches to optimizing smear microscopy, such as light-emitting diode fluorescence microscopy and same-day sputum collection strategies...
  12. pmc Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study
    J Lucian Davis
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 6:e16321. 2011
    ..Few studies have evaluated the clinical impact of these tests in low-income countries with high burdens of TB and HIV...
  13. ncbi Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp
    Adithya Cattamanchi
    Department of Medicine, San Francisco General Hospital University of California, San Francisco, San Francisco, California 94143, USA
    Am J Trop Med Hyg 68:133-9. 2003
    ..Comparing the 3 studied genes, msp-2 results were most accurate, and analysis of this single gene effectively distinguished recrudescence from reinfection in our study population...
  14. pmc Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda
    Steve M Taylor
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America
    PLoS ONE 7:e49991. 2012
    ..Given the reliability of field diagnosis in our cohort, future studies in sub-Saharan Africa can investigate the clinical impact of these genotypes...
  15. pmc HIV-associated Pneumocystis pneumonia
    Laurence Huang
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, California 94110, USA
    Proc Am Thorac Soc 8:294-300. 2011
    ....
  16. pmc Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV
    Christina Yoon
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Curry International Tuberculosis Center, and HIV AIDS Division, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda Department of Epidemiology and Biostatistics, University of California, San Francisco, CA Department of Internal Medicine, University of California, San Francisco, CA Center for Global Health, Massachusetts General Hospital, Harvard Medical School, Boston, MA Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Boston, MA and Department of Medicine, Makerere University, Kampala, Uganda
    J Acquir Immune Defic Syndr 65:551-6. 2014
    ..We evaluated whether testing for C-reactive protein (CRP) improves patient selection for IPT...
  17. pmc Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis
    Raymund Dantes
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 7:e37956. 2012
    ..Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of tuberculosis (TB) transmission. However, their role in the clinical presentation and outcomes of TB has not been evaluated...
  18. pmc Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis
    John Z Metcalfe
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, San Francisco, CA, USA
    J Infect Dis 204:S1120-9. 2011
    ..The diagnostic value of interferon-γ release assays (IGRAs) for active tuberculosis in low- and middle-income countries is unclear...
  19. pmc Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study
    J Lucian Davis
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 5:e9859. 2010
    ..Therefore, we sought to assess the accuracy of symptoms, physical signs, and radiographic findings for diagnosing tuberculosis in this population in a low-income country with a high incidence of tuberculosis...
  20. pmc Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia
    Steve M Taylor
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA
    Diagn Microbiol Infect Dis 72:139-43. 2012
    ..These findings may partially explain the low incidence of Pneumocystis pneumonia in Uganda and other sub-Saharan African countries...
  21. pmc Mobile digital fluorescence microscopy for diagnosis of tuberculosis
    Asa Tapley
    School of Medicine, University of California, San Francisco, San Francisco, California, USA
    J Clin Microbiol 51:1774-8. 2013
    ..Future studies should evaluate the device when operated by health workers in low-resource settings, the feasibility of image transmission and analysis by experienced microscopists, and the accuracy of automated image analysis algorithms...
  22. pmc Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis
    David W Dowdy
    Department of Medicine, University of California, San Francisco, California, United States of America
    PLoS Med 8:e1001063. 2011
    ....
  23. pmc Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms
    Robert J Blount
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
    PLoS ONE 7:e51545. 2012
    ..Little is known about the serologic responses to Pneumocystis jirovecii major surface glycoprotein (Msg) antigen in African cohorts, or the IgM responses to Msg in HIV-positive and HIV-negative persons with respiratory symptoms...
  24. pmc Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects
    John Z Metcalfe
    San Francisco General Hospital, University of California, 94110 0111, USA
    Am J Respir Crit Care Med 181:87-93. 2010
    ..Objectives: To determine whether the addition of quantitative IGRA results to a prediction model incorporating clinical criteria improves risk stratification of smear-negative-tuberculosis suspects...
  25. pmc Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis
    J Lucian Davis
    Pulmonary and Critical Care Medicine Division, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA 94110, USA
    Lancet Infect Dis 13:147-54. 2013
    ..To inform policy recommendations by a WHO-convened Expert Group, we aimed to assess the accuracy of sputum smear examination with strategies for obtaining sputum on 1 day compared with strategies for obtaining sputum over 2 days...
  26. pmc Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis
    J Lucian Davis
    Department of Medicine, San Francisco General Hospital and University of California, San Francisco, California 94110, USA
    Clin Infect Dis 48:725-32. 2009
    ..Few studies have assessed their performance among patients infected with HIV, and no studies have assessed their performance with oral wash specimens, which may be easier to obtain than sputum samples...
  27. pmc Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007
    John Z Metcalfe
    University of California, San Francisco, California, USA
    Emerg Infect Dis 16:1403-9. 2010
    ..In multivariate analysis, the katG S315T mutation (odds ratio 11.2, 95% confidence interval 2.2-Yen; p = 0.004), but not strain lineage, was independently associated with case clustering...
  28. pmc The lung microbiome of Ugandan HIV-infected pneumonia patients is compositionally and functionally distinct from that of San Franciscan patients
    Shoko Iwai
    Division of Gastroenterology, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 9:e95726. 2014
    ..Ugandan pneumonia-associated airway microbiome is compositionally and functionally distinct from those detected in comparable patients in developed countries, a feature which may contribute to adverse outcomes in this population. ..
  29. pmc A transcriptional signature for active TB: have we found the needle in the haystack?
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS Med 10:e1001539. 2013
    b>Adithya Cattamanchi and colleagues reflect on recent research by Michael Levin and coworkers into the use of whole blood mRNA expression signatures to detect tuberculosis...
  30. doi Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections
    Sofya Tokman
    Department of Internal Medicine, University of California, San Francisco, CA, USA Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA, USA
    Respirology 19:382-8. 2014
    ..We sought to determine if elevated serum procalcitonin is associated with increased in-hospital mortality and to combine serum procalcitonin with available clinical characteristics to create a clinically useful prognostic model...
  31. pmc Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 56:230-8. 2011
    ..To determine whether interferon-gamma release assays (IGRAs) improve the identification of HIV-infected individuals who could benefit from latent tuberculosis infection therapy...
  32. pmc Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services
    Jlucian Davis
    Divisions of Pulmonary and Critical Care Medicine, Department of Medicine, San Francisco General Hospital, California
    Am J Respir Crit Care Med 184:362-7. 2011
    ..Real-time monitoring and evaluation of adherence to widely endorsed standards of tuberculosis care might facilitate improved case finding...
  33. pmc Rapid Molecular Testing for TB to Guide Respiratory Isolation in the U.S.: A Cost-Benefit Analysis
    Alexander J Millman
    Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America PRIME Residency Program, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 8:e79669. 2013
    ..No previous studies have examined the costs of molecular testing as a replacement for smear microscopy in this setting...
  34. doi Interferon-γ release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders
    Rachel Smith
    Department of Medicine, University of California, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, CA, USA
    Curr Opin Rheumatol 23:377-84. 2011
    ..To provide a narrative synthesis of evidence on interferon-gamma release assays (IGRAs) for the diagnosis of latent tuberculosis infection (LTBI) in individuals with immune-mediated inflammatory disorders (IMIDs)...
  35. ncbi Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial
    Grant Dorsey
    Department of Medicine, San Francisco General Hospital, University of California, 94110, USA
    Lancet 360:2031-8. 2002
    ..We aimed to compare the short-term and long-term effectiveness of three antimalarial regimens in children from Kampala, Uganda...
  36. pmc Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice
    John Z Metcalfe
    University of California, San Francisco, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, 1001 Potrero Avenue, Room 5K1, San Francisco, CA 94110 0111, USA
    Am J Respir Crit Care Med 187:206-11. 2013
    ..Although IFN-γ release assays (IGRAs) are widely used to screen for Mycobacterium tuberculosis infection in high-income countries, published data on repeatability are limited...
  37. ncbi Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria
    Daniel Kyabayinze
    Department of Biochemistry, Makerere University Medical School, Kampala, Uganda
    Am J Trop Med Hyg 69:247-52. 2003
    ..7, P = 0.009). These results support a previously proposed method of predicting clinical outcomes based on the prevalence of these two mutations...